Perioperative Colchicine for TKA

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

March 1, 2026

Conditions
Osteoarthritis of KneeRecovery Following Primary Total Knee ArthroplastyPerioperative Pain Control
Interventions
DRUG

Colchicine 1.8 mg (loading dose) + Dextrose Oral Placebo

This intervention will be used for individuals in arm A of the study who will receive a loading dose of colchicine (1.8 mg) on postoperative day 0, and will then be given placebo oral dextrose pills to take twice daily on postoperative days 1-3

DRUG

Colchicine 1.8 mg + 0.6 mg

This intervention is will be given to patients in arm B of the study who will receive a loading dose of colchicine (1.8 mg) on postoperative day 0, followed by a maintenance does of colchicine (0.6 mg) to be taken twice daily on postoperative days 1-3.

DRUG

Dextrose Oral Placebo

This intervention will be for patients in arm C, the placebo arm. These patients will receive oral dextrose pills to be taken once on postoperative day 0, and twice daily on postoperative days 1-3.

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

St. Luke's Hospital, Kansas City, Missouri

OTHER

lead

Geisinger Clinic

OTHER